RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China
- PMID: 32272907
- PMCID: PMC7146988
- DOI: 10.1186/s12885-020-06779-4
RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China
Abstract
Background: RIPK1 (receptor-interacting protein kinase-1) plays a role in cancer development, whereas no clear studies focused on the cervical cancer. The objective of this study was to evaluate the relationship between RIPK1 polymorphisms and cervical cancer risk among the Uyghur population.
Methods: We performed a case-control study including 342 cervical cancer patients and 498 age-matched healthy controls. Four RIPK1 genetic variants (rs6907943, rs2077681, rs9503400 and rs17548629) were genotyped with Agena MassARRAY platform. The associations between RIPK1 polymorphisms and cervical cancer risk were assessed under Binary logistic regression models. False discovery rate (FDR) was used to improve the results reliability.
Results: The results showed rs2077681 was significantly associated with cervical cancer risk under various genetic models (codominant: OR = 3.14, 95% CI = 1.40-7.07, p = 0.006, FDR-p = 0.018; recessive: OR = 3.20, 95% CI = 1.43-7.16, p = 0.005, FDR-0.018). The stratified analysis indicated that the relationships of rs6907946, rs9503400 and rs17548629 with cervical cancer risk were statistically significant in the subgroup of clinical stage (p < 0.05).
Conclusion: Our findings demonstrated that RIPK1 polymorphisms were associated with cervical cancer susceptibility among the Uyghur population in China, and RIPK1 polymorphisms might be involved in the development of cervical cancer.
Keywords: Case-control study; Cervical cancer; RIPK1; Uyghur.
Conflict of interest statement
All authors certify that we have no conflict of interest in this study.
Similar articles
-
CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.Mol Genet Genomic Med. 2019 May;7(5):e626. doi: 10.1002/mgg3.626. Epub 2019 Mar 4. Mol Genet Genomic Med. 2019. PMID: 30829464 Free PMC article.
-
TNFAIP8L1 and FLT1 polymorphisms alter the susceptibility to cervical cancer amongst uyghur females in China.Biosci Rep. 2019 Jul 18;39(7):BSR20191155. doi: 10.1042/BSR20191155. Print 2019 Jul 31. Biosci Rep. 2019. PMID: 31289124 Free PMC article.
-
Single-nucleotide polymorphism rs17548629 in RIPK1 gene may be associated with lung cancer in a young and middle-aged Han Chinese population.Cancer Cell Int. 2020 Apr 30;20:143. doi: 10.1186/s12935-020-01215-w. eCollection 2020. Cancer Cell Int. 2020. PMID: 32368189 Free PMC article.
-
Analysis of HLA-DQB1 allele polymorphisms in Uyghur women with cervical cancer.Genet Mol Res. 2015 Dec 17;14(4):17252-61. doi: 10.4238/2015.December.16.25. Genet Mol Res. 2015. PMID: 26681219
-
The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.Arch Gynecol Obstet. 2016 Sep;294(3):579-88. doi: 10.1007/s00404-016-4037-6. Epub 2016 Feb 15. Arch Gynecol Obstet. 2016. PMID: 26879954 Review.
Cited by
-
Receptor-interacting protein kinase 2 is associated with tumor immune infiltration, immunotherapy-related biomarkers, and affects gastric cancer cells growth in vivo.J Cancer. 2024 Jan 1;15(1):176-191. doi: 10.7150/jca.90008. eCollection 2024. J Cancer. 2024. PMID: 38164277 Free PMC article.
-
RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesis.Discov Oncol. 2023 Jul 18;14(1):131. doi: 10.1007/s12672-023-00725-z. Discov Oncol. 2023. PMID: 37462822 Free PMC article.
-
Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis.Dose Response. 2020 Jul 29;18(3):1559325820941351. doi: 10.1177/1559325820941351. eCollection 2020 Jul-Sep. Dose Response. 2020. PMID: 32774193 Free PMC article.
-
Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.Trends Biochem Sci. 2022 Apr;47(4):342-351. doi: 10.1016/j.tibs.2021.12.004. Epub 2022 Jan 5. Trends Biochem Sci. 2022. PMID: 34998669 Free PMC article. Review.
-
Clinicopathological and prognosis significance of RIPK1 in patients with cervical squamous cell carcinoma: a retrospective cohort study.Transl Cancer Res. 2023 May 31;12(5):1315-1324. doi: 10.21037/tcr-23-578. Epub 2023 May 18. Transl Cancer Res. 2023. PMID: 37304533 Free PMC article.
References
-
- Zhu S, Weng J, Zhu HY. Study on the prokaryotic expression of human papillomavirus type16 E7 protein and its role in cervical cancer treatment. Mod Prev Med. 2009;36(22):4317.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous